274 related articles for article (PubMed ID: 23317218)
1. Intragenic DNA methylation concomitant with repression of ATP4B and ATP4A gene expression in gastric cancer is a potential serum biomarker.
Raja UM; Gopal G; Rajkumar T
Asian Pac J Cancer Prev; 2012; 13(11):5563-8. PubMed ID: 23317218
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of Atp4a concomitant with intragenic DNA demethylation for cancer inhibition in a gastric cancer model.
Cao D; Zhao D; Jia Z; Su T; Zhang Y; Wu Y; Wu M; Tsukamoto T; Oshima M; Jiang J; Cao X
Life Sci; 2020 Feb; 242():117214. PubMed ID: 31884095
[TBL] [Abstract][Full Text] [Related]
3. Silencing of ATP4B of ATPase H
Lin S; Lin B; Wang X; Pan Y; Xu Q; He JS; Gong W; Xing R; He Y; Guo L; Lu Y; Wang JM; Huang J
Oncol Res; 2017 Mar; 25(3):317-329. PubMed ID: 28281974
[TBL] [Abstract][Full Text] [Related]
4. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
[TBL] [Abstract][Full Text] [Related]
5. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
7. SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer.
Gopal G; Raja UM; Shirley S; Rajalekshmi KR; Rajkumar T
Cancer Genet; 2013 May; 206(5):174-82. PubMed ID: 23830730
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of somatostatin in gastric cancer.
Jackson K; Soutto M; Peng D; Hu T; Marshal D; El-Rifai W
Dig Dis Sci; 2011 Jan; 56(1):125-30. PubMed ID: 20927589
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation and expression of TIMP3 gene in gastric cancer.
Guan Z; Zhang J; Song S; Dai D
Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers.
Tomii K; Tsukuda K; Toyooka S; Dote H; Hanafusa T; Asano H; Naitou M; Doihara H; Kisimoto T; Katayama H; Pass HI; Date H; Shimizu N
Int J Cancer; 2007 Feb; 120(3):566-73. PubMed ID: 17096329
[TBL] [Abstract][Full Text] [Related]
17. CpG Islands Methylation Analysis of CDH11, EphA5, and HS3ST2 Genes in Gastric Adenocarcinoma Patients.
Eyvazi S; Khamaneh AM; Tarhriz V; Bandehpour M; Hejazi MS; Sadat ATE; Sepehri B
J Gastrointest Cancer; 2020 Jun; 51(2):579-583. PubMed ID: 31407253
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo.
Du Y; Liu Z; Gu L; Zhou J; Zhu BD; Ji J; Deng D
BMC Cancer; 2012 Jun; 12():249. PubMed ID: 22703336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
